{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"61.200","rs_stock_flag":false,"fiscal_year_end":"2025年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"276,342,331","primaryexch":"香港交易所","ric":"2629.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BP0R4D6","am":"94.45","iv":"","ew_strike":"","as":"57.850","geographic_focus":null,"incorpin":"開曼群島","etp_baseCur":null,"ew_amt_os":"","bd":"57.750","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"27.050","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"朱興奮","underlying_ric":"2629.HK","hi52":"75.250","issuer_name":"Mirxes Holding Co. Ltd. - B","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"57.500","mkt_cap":"15.98","f_aum_hkd":null,"ew_sub_per_to":"","ls":"57.850","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 藥品及生物科技","ew_desc":null,"inception_date":"","nc":"-1.900","aum":"","issued_shares_class_B":null,"vo":"1.59","secondary_listing_flag":false,"listing_date":"2025年5月23日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"Mirxes Holding Co. Ltd. - B","nm_s":"MIRXES-B","sym":"2629","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"MiRXES Holding Company Limited是一家專注於早期癌症檢測和精準醫療的微核糖核酸（miRNA）技術公司。該公司開發並商業化精準、非侵入性且價格合理的血液miRNA檢測試劑盒產品，用於癌症和其他疾病的早期檢測。該公司業務分部包括傳染病業務以及早期檢測和精準多組學業務。該公司的解決方案涵蓋癌症篩檢、臨床測序、癌症治療選擇和傳染病領域。該公司擁有核心產品GASTROClear、另外兩款已商業化產品LUNGClear和Fortitude，以及六款處於臨床前階段的候選產品。GASTROClear是一種以血液為基礎的miRNA檢測組，包含12種用於胃癌篩檢的miRNA生物標記。LUNGClear是其肺癌篩檢候選產品，是一種由多中心研究發現和驗證的miRNA生物標記組成的檢測組。該公司提供完整的COVID-19檢測解決方案。","op":"59.600","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"生物技術","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"香港銅鑼灣<br/>希慎道33號<br/>利園一期<br/>19樓1920室","pc":"-3.18","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"59.750","isin":"KYG6152E1052","moneyness":""}},"qid":"1759074159071"}
